´ëÇÑÁ¾¾ç³»°úÇÐȸ Best of ASCO (American Society of Clinical Oncology) 2022 in Korea : 2022-08-20±³À°ÀÏÀÚ : 2022-08-20
±³À°Àå¼Ò : °æÁÖ È¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300È£
±³À°ÁÖÁ¦ :
Best of ASCO (American Society of Clinical Oncology) 2022 in KoreaÁÖÃÖ±â°ü : ´ëÇÑÁ¾¾ç³»°úÇÐȸ(17.5 ¸íĪº¯°æ Çѱ¹ÀÓ»ó¾ÏÇÐȸ)
´ã´çÀÚ : ±è¹ÎÈñ
¿¬¶ôó : 02-735-2859
À̸ÞÀÏ :
meetings@ksmo.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
°æ»óºÏµµ±³À°½Ã°£ : 6 ½Ã°£ 15ºÐ
¼¼ºÎ¼ö°·á : 80,000¿ø
ºñ°í »çÀüµî·Ï ȸ¿ø 4¸¸¿ø, ºñȸ¿ø Àü¹®ÀÇ 6¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 08-20 300È£ 08:00~08:15 Changes in ASCO 2022 °¼®À±(¾ÆÁִ뺴¿ø)
±³À°½Ã°£ 08-20 300È£ 08:15~08:45 Head and Neck ¹ÚÁöÇö(°Ç±¹´ëº´¿ø)
±³À°½Ã°£ 08-20 300È£ 08:45~09:15 Lung Cancer Á¤Çö¾Ö(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 08-20 300È£ 09:15~09:45 Palliative Care Á¤¹Î±Ô(¿¬¼¼¾Ïº´¿ø)
±³À°½Ã°£ 08-20 300È£ 09:45~10:15 Developmental Therapeutics ±èŹÎ(¼¿ï´ëº´¿ø)
ÈÞ½Ä 08-20 300È£ 10:15~10:40 ÈÞ½Ä ()
±³À°½Ã°£ 08-20 300È£ 10:40~11:10 Breast Cancer ¾ÈÈñ°æ(°¡Ãµ´ë±æº´¿ø)
±³À°½Ã°£ 08-20 300È£ 11:10~11:40 GU Cancers ÀÓÁÖÇÑ(ÀÎÇϴ뺴¿ø)
±³À°½Ã°£ 08-20 300È£ 11:40~12:10 GY Cancers ÀÌÀÎÈñ(Ä¥°î°æºÏ´ëº´¿ø)
±³À°½Ã°£ 08-20 300È£ 12:10~12:40 Lymphoma ÀÌ°æ¿ø(°æ»ó´ëº´¿ø)
±³À°½Ã°£ 08-20 300È£ 12:40~13:10 Maximizing Clinical Benefit with CDK4 6 inhibitors ¹Ú¿¬Èñ(»ï¼º¼¿ïº´¿ø)
ÈÞ½Ä 08-20 300È£ 13:10~13:30 ÈÞ½Ä ()
±³À°½Ã°£ 08-20 300È£ 13:30~13:45 The first report of K Umbrella Gastric Cancer Study ¶ó¼±¿µ(¿¬¼¼¾Ïº´¿ø)
±³À°½Ã°£ 08-20 300È£ 13:45~14:15 Colon Cancer ÀÌ´ë¿ø(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 08-20 300È£ 14:15~14:45 Pancreatic Cancers õÀç°æ(ºÐ´çÂ÷º´¿ø)
±³À°½Ã°£ 08-20 300È£ 14:45~15:15 Update on Radiotherapy ¹ÚÁ¾¹«(Ä¥°î°æºÏ´ëº´¿ø)
±âŸ 08-20 300È£ 15:15~15:20 Closing Remarks ¾ÈÁß¹è(KSMO ÀÌ»çÀå)
±³À°ÀÏÀÚ 2022-08-20 (22ÀÏ ÀÌÀü) ±³À°Àå¼Ò °æÁÖ È¹éÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300È£
±³À°ÁÖÁ¦ Best of ASCO (American Society of Clinical Oncology) 2022 in Korea
ÁÖÃÖ±â°ü ´ëÇÑÁ¾¾ç³»°úÇÐȸ(17.5 ¸íĪº¯°æ Çѱ¹ÀÓ»ó¾ÏÇÐȸ) ½ÃÇà±â°ü(ÁöºÎ/°ú)
´ã´çÀÚ ±è¹ÎÈñ ¿¬¶ôó 02-735-2859
À̸ÞÀÏ
meetings@ksmo.or.kr ±³À°Á¾·ù ³»°ú
Âü¼®¿¹»óÀοø 700¸í Èñ¸ÁÆòÁ¡ 6Á¡
Áö¿ª °æ»óºÏµµ ±³À°½Ã°£ 6 ½Ã°£ 15ºÐ
¼ö°·á ÀÖÀ½
¼¼ºÎ¼ö°·á 80,000¿ø
ºñ°í »çÀüµî·Ï ȸ¿ø 4¸¸¿ø, ºñȸ¿ø Àü¹®ÀÇ 6¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 08-20 300È£ 08:00~08:15 Changes in ASCO 2022 °¼®À±(¾ÆÁִ뺴¿ø)
±³À°½Ã°£ 08-20 300È£ 08:15~08:45 Head and Neck ¹ÚÁöÇö(°Ç±¹´ëº´¿ø)
±³À°½Ã°£ 08-20 300È£ 08:45~09:15 Lung Cancer Á¤Çö¾Ö(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 08-20 300È£ 09:15~09:45 Palliative Care Á¤¹Î±Ô(¿¬¼¼¾Ïº´¿ø)
±³À°½Ã°£ 08-20 300È£ 09:45~10:15 Developmental Therapeutics ±èŹÎ(¼¿ï´ëº´¿ø)
ÈÞ½Ä 08-20 300È£ 10:15~10:40 ÈÞ½Ä ()
±³À°½Ã°£ 08-20 300È£ 10:40~11:10 Breast Cancer ¾ÈÈñ°æ(°¡Ãµ´ë±æº´¿ø)
±³À°½Ã°£ 08-20 300È£ 11:10~11:40 GU Cancers ÀÓÁÖÇÑ(ÀÎÇϴ뺴¿ø)
±³À°½Ã°£ 08-20 300È£ 11:40~12:10 GY Cancers ÀÌÀÎÈñ(Ä¥°î°æºÏ´ëº´¿ø)
±³À°½Ã°£ 08-20 300È£ 12:10~12:40 Lymphoma ÀÌ°æ¿ø(°æ»ó´ëº´¿ø)
±³À°½Ã°£ 08-20 300È£ 12:40~13:10 Maximizing Clinical Benefit with CDK4 6 inhibitors ¹Ú¿¬Èñ(»ï¼º¼¿ïº´¿ø)
ÈÞ½Ä 08-20 300È£ 13:10~13:30 ÈÞ½Ä ()
±³À°½Ã°£ 08-20 300È£ 13:30~13:45 The first report of K Umbrella Gastric Cancer Study ¶ó¼±¿µ(¿¬¼¼¾Ïº´¿ø)
±³À°½Ã°£ 08-20 300È£ 13:45~14:15 Colon Cancer ÀÌ´ë¿ø(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 08-20 300È£ 14:15~14:45 Pancreatic Cancers õÀç°æ(ºÐ´çÂ÷º´¿ø)
±³À°½Ã°£ 08-20 300È£ 14:45~15:15 Update on Radiotherapy ¹ÚÁ¾¹«(Ä¥°î°æºÏ´ëº´¿ø)
±âŸ 08-20 300È£ 15:15~15:20 Closing Remarks ¾ÈÁß¹è(KSMO ÀÌ»çÀå)